[Etiopathogenic problems in multiple sclerosis. Etiology, pathogenesis and therapeutic concept].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000818:Animals; D000906:Antibodies / Q000032:analysis; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002555:Cerebrospinal Fluid / Q000276:immunology; D004679:Encephalomyelitis / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology / Q000382:microbiology / Q000473:pathology; D009457:Neuroglia / Q000276:immunology; D011817:Rabbits; D014777:Virus Diseases
D000305:Adrenal Cortex Hormones; D000906:Antibodies; D000961:Antilymphocyte Serum; D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents
Atiopathogenetische Probleme der Multiplen Sklerose. Zur Atiologie, Pathogenese und Therapiekonzeption.